The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys (Q44343876)

2 December 2017

The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys (English)

1 reference

2 December 2017

0 references

0 references

0 references

0 references

1

1 reference

2 December 2017

Gianluigi Tanda

2

0 references

author name string

Patrik Munzar

series ordinal

3

1 reference

PubMed ID

14668977

2 December 2017

Steven R Goldberg

series ordinal

4

1 reference

2 December 2017

11 December 2003

1 reference

2 December 2017

1 reference

2 December 2017

173

1 reference

2 December 2017

1-2

1 reference

2 December 2017

186-194

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-003-1693-6

2 December 2017

0 references

cites work

Naloxone attenuation of the effect of cocaine on rewarding brain stimulation.

1 reference

12 December 2020

Naloxone antagonizes GABA(A)/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes

1 reference

12 December 2020

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

1 reference

12 December 2020

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

12 December 2020

Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys

1 reference

12 December 2020

Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

1 reference

12 December 2020

Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats

1 reference

12 December 2020

Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system

1 reference

12 December 2020

The cannabinoid receptors.

1 reference

12 December 2020

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

12 December 2020

Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids

1 reference

12 December 2020

Cannabinoid pharmacology

1 reference

12 December 2020

Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice

1 reference

12 December 2020

Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.

1 reference

12 December 2020

Naltrexone-induced alterations in human ethanol intoxication.

1 reference

12 December 2020

Dependence on tetrahydrocannabinol in rhesus monkeys.

1 reference

12 December 2020

Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor

1 reference

12 December 2020

Pharmacotherapy of addictions

1 reference

12 December 2020

Interaction between naltrexone and oral THC in heavy marijuana smokers.

1 reference

12 December 2020

Pharmacological and biochemical interactions between opioids and cannabinoids.

1 reference

12 December 2020

Molecular mechanisms of opiate receptor coupling to G proteins and effector systems

1 reference

12 December 2020

A comparison of some pharmacological actions of morphine and ?9-tetrahydrocannabinol in the mouse

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys.

1 reference

12 December 2020

Preparation of 9-tetrahydrocannabinol for intravenous injection.

1 reference

12 December 2020

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

1 reference

12 December 2020

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

12 December 2020

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain

1 reference

12 December 2020

Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant rats

1 reference

12 December 2020

Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.

1 reference

12 December 2020

Stimulus effects of morphine in the monkey: quantitative analysis of antagonism.

1 reference

12 December 2020

Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys

1 reference

12 December 2020

Naloxone depresses cocaine self-administration and delays its initiation on the following day.

1 reference

12 December 2020

Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism

1 reference

12 December 2020

GABA receptor-linked chloride channels and the behavioral effects of naltrexone in rats.

1 reference

12 December 2020

Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey.

1 reference

12 December 2020

Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.

1 reference

12 December 2020

Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.

1 reference

12 December 2020

Operant analysis of human heroin self-administration and the effects of naltrexone.

1 reference

12 December 2020

The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive

1 reference

12 December 2020

Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.

1 reference

12 December 2020

Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

1 reference

12 December 2020

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

1 reference

12 December 2020

Naltrexone reduces ethanol- and/or water-reinforced responding in rhesus monkeys: effect depends upon ethanol concentration.

1 reference

12 December 2020

Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys.

1 reference

12 December 2020

The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey

1 reference

12 December 2020

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

1 reference

12 December 2020

Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

1 reference

12 December 2020

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

1 reference

12 December 2020

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

1 reference

12 December 2020

Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.

1 reference

12 December 2020

10.1007/S00213-003-1693-6

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

14668977